Original Article

Leukemoid Reactions Complicating Colitis due to Clostridium difficile

Authors: Mark A. Marinella, MD, Steven D. Burdette, MD, Roger Bedimo, MD, Ronald J. Markert, PHD

Abstract

Background: We sought to describe the characteristics of patients who had Clostridium difficile colitis complicated by leukemoid reactions (total leukocyte count greater than 35 × 109/L) and to determine whether this complication is associated with higher morbidity or mortality than C difficile colitis without leukemoid reactions.


Methods: We performed a retrospective case series analysis of patients with a positive fecal assay for C difficile toxin and a peak leukocyte count greater than 35 × 109/L during 1998 and 1999. Twenty cases that met these criteria were compared with 65 randomly selected control patients (patients with a positive C difficile toxin and a peak leukocyte count less than 35 × 109/L).


Results: The mean peak leukocyte count was 52 ± 18.2 × 109/L (± SD) in the case group and 14.9 ± 6.5 × 109/L in the control group. Patients with a leukemoid reaction had a lower temperature, a lower serum albumin level, and a higher hematocrit value. Multivariable logistic regression showed respiratory tract infection and lower temperature to be independent predictors of a leukemoid reaction. There were 10 deaths (50%) in the leukemoid reaction group and 5 deaths (7.7%) in the control group. All seven patients with a peak leukocyte count greater than 50 × 109/L died, compared with eight deaths (10.3%) among the remaining 78 patients whose peak leukocyte count was less than 50 × 109/L.


Conclusion: Patients with C difficile colitis and a leukocyte count greater than 35 × 109/L have a poor prognosis with a much higher mortality rate than patients who have C difficilecolitis without a leukemoid reaction.


Key Points


* Leukemoid reactions in patients with Clostridium difficile colitis are associated with lower body temperature and hypoalbuminemia.


* A respiratory tract infection in patients with C difficile colitis is an independent predictor of the presence of a leukemoid reaction.


* Patients with leukemoid reactions in association with C difficile colitis have a higher mortality rate than patients who have C difficile colitis without leukemoid reactions.


* The mortality rate for C difficile colitis with a peak leukocyte count greater than 50 × 109/L is exceedingly high, being 100% in this series.

This content is limited to qualifying members.

Existing members, please login first

If you have an existing account please login now to access this article or view purchase options.

Purchase only this article ($25)

Create a free account, then purchase this article to download or access it online for 24 hours.

Purchase an SMJ online subscription ($75)

Create a free account, then purchase a subscription to get complete access to all articles for a full year.

Purchase a membership plan (fees vary)

Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.

References

1. Grundfest-Broniatowski S, Quader M, Alexander F, et al. Clostridium difficile colitis in the critically ill.Dis Colon Rectum 1996;39:619–623.
 
2. Kelly CP, LaMont JT. Clostridium difficile infection. Annu Rev Med 1998;49:375–390.
 
3. Fekety R, Shah AB. Diagnosis and treatment of Clostridium difficile colitis. JAMA 1993;269:71–79.
 
4. Bagby GC. Leukopenia and leukocytosis, in Goldman L, Bennett JC (eds): Cecil's Textbook of Medicine. Philadelphia, W.B. Saunders Co., 2000, ed 21, pp 919–933.
 
5. Counihan TC, Roberts PL. Pseudomembranous colitis. Surg Clin North Am 1993;73:1063–1075.
 
6. Kelly CP, Pothoulakis C, LaMont JT. Clostridium difficile colitis. N Engl J Med 1994;330:257–262.
 
7. Anand A, Bashey B, Mir T, et al. Epidemiology, clinical manifestations, and outcome of Clostridium difficile colitis. Am J Gastroenterol 1994;89:519–523.
 
8. Taege AJ, Adal KA. Clostridium difficile diarrhea and colitis: A clinical review. Cleve Clin J Med1999;66:503–507.
 
9. Bartlett JG. How to identify the cause of antibiotic-associated diarrhea. J Crit Illn 1994;9:1063–1067.
 
10. McKee LC. Excess leukocytosis (leukemoid reactions) associated with malignant diseases. South Med J 1985;78:1475–1482.
 
11. Burris AS. Leukemoid reaction associated with severe diabetic ketoacidosis. South Med J1986;79:647–648.
 
12. Marinella MA. Extreme leukemoid reaction associated with retroperitoneal hemorrhage. Arch Intern Med 1998;158:300–301.
 
13. Medich DS, Lee KK, Simmons RL, et al. Laparotomy for fulminant pseudomembranous colitis. Arch Surg 1992;127:847–853.
 
14. McGregor JA, Soper DE, Lovell G, et al. Maternal deaths associated with Clostridium sordelliinfection. Am J Obstet Gynecol 1989;161:987–994.
 
15. Popoff MR. Purification and characterization of Clostridium sordellii lethal toxin and cross-reactivity with Clostridium difficile cytotoxin. Infect Immun 1987;55:35–43.
 
16. Katner HP, Pankey GA, Bonis SL. Fatal Clostridium difficile cellulitis. Pediatr Infect Dis J1987;6:294–295.
 
17. Amon SS, Mills DC, Day PA, et al. Rapid death of infant rhesus monkeys injected with Clostridium difficile toxins A and B: Physiologic and pathologic basis. J Pediatr 1984;104:34–40.
 
18. Zimmerman JL, Taylor RW. Sepsis and septic shock, in Civetta JM, Taylor RW, Kirby RR (eds):Critical Care. Philadelphia, Lippincott-Raven, 1997, ed 3, pp 405–412.
 
19. Marinella MA, Markert RJ. Admission serum albumin and length of hospitalization in elderly patients. South Med J 1998;91:851–854.
 
20. Ramaswamy R, Grover H, Corpuz M, et al. Prognostic criteria in Clostridium difficile colitis. Am J Gastroenterol 1996;91:460–464.
 
21. Rybolt AH, Bennett RG, Laughon BE, et al. Protein-losing enteropathy associated with Clostridium difficile infection. Lancet 1989;1:1353–1355.
 
22. Marinella MA, Pearson C, Chenoweth C. The stethoscope: A potential source of nosocomial infection. Arch Intern Med 1997;157:786–789.